Koen Vandyck,Geerwin Yvonne Paul Haché,Stefaan Julien Last,David Craig Mc Gowan,Geert Rombouts,Wim Gaston Verschueren,Pierre Jean-Marie Bernard Raboisson
申请号：
US14891864
公开号：
US09884818B2
申请日:
2014.05.16
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Inhibitors of HBV replication of Formula (ID)including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein X, Ra to Rd and R4 to R6 have the meaning as defined herein. The present invention also relates to processes for preparing compounds of Formula (ID), pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy.
